Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mesenchymal stem/stromal cell–based therapies for COVID-19: First iteration of a living systematic review and meta-analysis
Aidan M. Kirkham, Madeline Monaghan, Adrian Bailey, et al.
Cytotherapy (2022) Vol. 24, Iss. 6, pp. 639-649
Open Access | Times Cited: 18

Showing 18 citing articles:

Registered clinical trials investigating treatment with cell-derived extracellular vesicles: a scoping review
An Duong, Gaganvir Parmar, Aidan M. Kirkham, et al.
Cytotherapy (2023) Vol. 25, Iss. 9, pp. 939-945
Closed Access | Times Cited: 35
Updated Living Systematic Review and Meta-analysis of Controlled Trials of Mesenchymal Stromal Cells to Treat COVID-19: A Framework for Accelerated Synthesis of Trial Evidence for Rapid Approval—FASTER Approval
Aidan M. Kirkham, Adrian Bailey, Madeline Monaghan, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 7, pp. 675-687
Open Access | Times Cited: 28
Safety and efficacy of mesenchymal stem cells in severe/critical patients with COVID-19: A systematic review and meta-analysis
Weiqi Yao, Haibo Dong, Ji Qi, et al.
EClinicalMedicine (2022) Vol. 51, pp. 101545-101545
Open Access | Times Cited: 21
Efficacy and safety of human umbilical cord-derived mesenchymal stem cells for COVID-19 pneumonia: a meta-analysis of randomized controlled trials
Qinxue Liu, Fengjie Ma, Yizhi Zhong, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Acute respiratory distress vs healthy lung environments differently affect mesenchymal stromal cell extracellular vesicle miRNAs
Sara Rolandsson Enes, Irakli Dzneladze, Thomas H. Hampton, et al.
Cytotherapy (2025)
Closed Access
Nebulized mesenchymal stem cell-derived exosomes attenuate airway inflammation in a rat model of chronic obstructive pulmonary disease
Min Wang, Yuxin Hao, Wei He, et al.
Cellular Immunology (2025) Vol. 409-410, pp. 104933-104933
Closed Access
Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19
Ju‐Pi Li, Kang‐Hsi Wu, Wan‐Ru Chao, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 15, pp. 8196-8196
Open Access | Times Cited: 18
Systematic review and meta-analysis of randomized controlled trials of mesenchymal stromal cells to treat coronavirus disease 2019: is it too late?
Aidan M. Kirkham, Adrian Bailey, Risa Shorr, et al.
Cytotherapy (2022) Vol. 25, Iss. 3, pp. 341-352
Open Access | Times Cited: 15
Potential application of mesenchymal stromal cells as a new therapeutic approach in acute respiratory distress syndrome and pulmonary fibrosis
Giulia Gazzaniga, M Voltini, Alessandro Carletti, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 2
An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells Committee editorial on overcoming limitations in clinical trials of mesenchymal stromal cell therapy for coronavirus disease-19: time for a global registry
Daniel J. Weiss, Anthony J. Filiano, Jacques Galipeau, et al.
Cytotherapy (2022) Vol. 24, Iss. 11, pp. 1071-1073
Open Access | Times Cited: 10
Methodological quality and reporting quality of COVID-19 living systematic review: a cross-sectional study
Jiefeng Luo, Zhe Chen, Dan Liu, et al.
BMC Medical Research Methodology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Short-term assays for mesenchymal stromal cell immunosuppression of T-lymphocytes
Maryanne C. Herzig, Barbara A. Christy, Robbie K. Montgomery, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review
Junxia Cao, Jia You, L. Wu, et al.
World Journal of Clinical Cases (2022) Vol. 10, Iss. 27, pp. 9714-9726
Open Access | Times Cited: 6
Update on the Use of Mesenchymal Stem Cells in the Treatment of Various Infectious Diseases Including COVID-19 Infection
Al-Anazi Khalid A, Al-Ansari Rehab Y
Journal of Stem Cell Therapy and Transplantation (2023) Vol. 7, Iss. 1, pp. 034-042
Open Access | Times Cited: 2
Characteristics of Living Systematic Review for COVID-19
Zhe Chen, Jiefeng Luo, Siyu Li, et al.
Clinical Epidemiology (2022) Vol. Volume 14, pp. 925-935
Open Access | Times Cited: 4
The function and effectiveness of MSCs in preclinical models of diseases
Z. Xie, Hu Zhou, Tingting Ou, et al.
IntechOpen eBooks (2024)
Closed Access
The Art of Stem Cell-Based Therapy
Jorge S. Burns
Advances in experimental medicine and biology (2023), pp. 1-12
Closed Access
Emerging role and therapeutic application of mesenchymal stem cell (MSC) and MSC-derived exosome in Coronavirus disease-2019 (COVID-19) infection
Ying Shi, Chaoping Yu, Zhuoyang Yu, et al.
IntechOpen eBooks (2023)
Open Access
Page 1

Scroll to top